Qure.ai's AI-driven chest X-ray solution for enhanced lung nodule detection gets USFDA clearance

New Delhi, Medical imaging solutions provider Qure.ai on Wednesday said it has received clearance from US health regulator for its artificial intelligence-enabled X-ray for detection of lung nodules. Qure's chest X-ray-based qXR-LN uses artificial intelligence (AI)to identify and localize lung nodules thereby helping in identifying potentially malignant pulmonary nodules, thus boosting the fight against lung cancer, the company said in a statement.

This also marks the 6th USFDA (United States Food and Drug Administration) clearance for Qure's chest X-ray based solutions, the company said.

The qXR for lung nodule is a cutting-edge detection software designed to identify and highlight regions indicative of suspected pulmonary nodules ranging from 6 to 30 mm in size.

Prashant Warier, Co-Founder and CEO of Qure.ai, said the company has already deployed and implemented this solution globally, and the USFDA clearance "marks yet another ground-breaking leap in our pioneering efforts to combat lung cancer".

"Our heightened emphasis on the North American marketplace solidifies our commitment to making a meaningful impact in the fight against this deadly disease and underscores our dedication to advancing healthcare through innovation, providing a transformative solution enhancing the early detection of cancer and ultimately improving patient outcomes," Warier said.